FDA
-
-
-
-
-
-
-
Organogenesis Holdings Inc. Reports Fourth Quarter 2025 Financial Results, Posts Record Revenue
-
-
-
-
-
-
-
Organogenesis Applauds CMS’s Significant Step In Payment Reform
-
-
-
-
-
-
-
Organogenesis Holdings Inc. Reports First Quarter 2025 Financial Results
-
-
-
-
-
-
-
Organogenesis Holdings Inc. Reports First Quarter 2024 Financial Results
-
-
-
-
-
-
-
Organogenesis Holding (ORGO) Appoints CEO Gary S. Gillheeney as Board Chair
-
-
-
-
-
-
-
Organogenesis Holdings Inc. Reports Second Quarter 2022 Financial Results
-
-
-
-
-
-
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Organogenesis, Paysafe, Revance Therapeutics, and Cloopen Group and Encourages Investors to Contact the
-
322,882 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

